The share of the US's scientific publications in the top 10% of applied microbiology and biotechnology is projected to slightly decline from 15.86% in 2024 to 15.09% by 2028. This continuous, albeit gradual, decrease suggests a slight reduction in the relative influence or visibility of US research within these fields. In 2023, the actual share was already slightly lower, indicating a continuing trend of marginal decline. Year-on-year changes depict a downward trend while the five-year Compound Annual Growth Rate (CAGR) reinforces this declining pattern.
Future trends to watch include the impact of global collaboration, funding shifts, and technological advances in biotechnology that could alter publication influence. Innovations and policy changes might also shape how US contributions compare worldwide.
